Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Armata Pharmaceuticals, Inc. Earnings Release 2003

Oct 30, 2003

34152_rns_2003-10-30_cc4267dd-08d3-4797-9a88-88a5f6b83c79.zip

Earnings Release

Open in viewer

Opens in your device viewer

8-K 1 v94064e8vk.htm FORM 8-K Targeted Genetics Corporation Form 8-K PAGEBREAK

Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 30, 2003

Targeted Genetics Corporation

(Exact name of registrant as specified in charter)

Washington 0-23930 91-1549568
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
1100 Olive Way, Suite 100, Seattle, Washington 98101
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (206) 623-7612

Not Applicable

(Former name or former address, if changed since last report)

1 PAGEBREAK

TOC

TABLE OF CONTENTS

Item 12. Results and Operations of Financial Condition.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1

/TOC

Table of Contents

link2 "Item 7. Exhibits."

Item 7. Exhibits.

(a) Financial statements of business acquired.

Not applicable.

(b) Pro forma financial information.

Not applicable.

(c) Exhibits.

Exhibit
No. Description
99.1 Press Release of Targeted Genetics Corporation dated
October 30, 2003

link2 "Item 12. Results and Operations of Financial Condition."

Item 12. Results and Operations of Financial Condition.

On October 30, 2003, Targeted Genetics Corporation issued a press release announcing its financial results for the quarter ended September 30, 2003. A copy of the press release is furnished as Exhibit 99.1 and is incorporated into this current report by reference. link1 "SIGNATURES"

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

By: /s/ Todd E. Simpson
Date: October 30, 2003 Todd E. Simpson
Vice President, Finance and
Administration and Chief Financial
Officer, Secretary and Treasurer
(Principal Financial and Accounting
Officer)

PAGEBREAK

Table of Contents

link1 "EXHIBIT INDEX"

EXHIBIT INDEX

Exhibit
No. Description
99.1 Press Release of Targeted Genetics Corporation dated
October 30, 2003